Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
BVF Partners L.P. is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments. Since its inception in 1993, BVF has strived to build concentrated, long-term investments in small-cap biotechnology companies while performing rigorous diligence and on-going monitoring of its investments. BVF is an equity hedge fund manager which primarily invests in small-cap biotech companies and is an evergreen fund specializing in early-stage financing. The firm prefers to invest in companies operating in the biotechnology sector.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences2
Q&A
- What is BVF Partners' primary investment focus?
- BVF Partners primarily focuses on the Health Tech & Life Sciences sector, with all of its known portfolio companies operating in this area.
- Can you name some of BVF Partners' portfolio companies?
- BVF Partners' portfolio includes BiolineRx, which develops oncology therapeutic pharmaceutical candidates, and KAHR Medical, focused on fusion proteins for treating cancer and autoimmune diseases.
- What is the typical investment range for BVF Partners?
- BVF Partners typically invests between $9.6M and $46.5M per round.
- When did BVF Partners make its most recent known investment?
- BVF Partners made a known investment in June 2021.
- What was BVF Partners' earliest known investment?
- BVF Partners' earliest known investment occurred in July 2017.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1993-11 |
|---|